Preclinical study of Ublituximab, a Glycoengineered anti-human CD20 antibody, in murine models of primary cerebral and intraocular B-cell lymphomas.
Ben Abdelwahed R, Donnou S, Ouakrim H, Crozet L, Cosette J, Jacquet A, Tourais I, Fournès B, Gillard Bocquet M, Miloudi A, Touitou V, Daussy C, Naud MC, Fridman WH, Sautès-Fridman C, Urbain R, Fisson S.
Ben Abdelwahed R, et al. Among authors: naud mc.
Invest Ophthalmol Vis Sci. 2013 May 1;54(5):3657-65. doi: 10.1167/iovs.12-10316.
Invest Ophthalmol Vis Sci. 2013.
PMID: 23611989